Your browser is no longer supported. Please, upgrade your browser.
Settings
PTX Pernix Therapeutics Holdings, Inc. daily Stock Chart
PTX [NASD]
Pernix Therapeutics Holdings, Inc.
Index- P/E- EPS (ttm)-17.00 Insider Own1.80% Shs Outstand11.24M Perf Week0.71%
Market Cap31.81M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float11.24M Perf Month-3.74%
Income-163.60M PEG- EPS next Q- Inst Own21.30% Short Float13.48% Perf Quarter-17.73%
Sales135.70M P/S0.23 EPS this Y22.10% Inst Trans10.58% Short Ratio8.69 Perf Half Y-27.06%
Book/sh-16.35 P/B- EPS next Y- ROA-54.90% Target Price30.00 Perf Year-17.25%
Cash/sh1.27 P/C2.22 EPS next 5Y4.00% ROE145.20% 52W Range1.83 - 7.15 Perf YTD45.88%
Dividend- P/FCF- EPS past 5Y-52.90% ROI-75.20% 52W High-60.42% Beta1.68
Dividend %- Quick Ratio0.70 Sales past 5Y18.40% Gross Margin70.20% 52W Low54.59% ATR0.13
Employees185 Current Ratio0.80 Sales Q/Q-6.50% Oper. Margin-93.60% RSI (14)40.79 Volatility2.75% 4.44%
OptionableYes Debt/Eq- EPS Q/Q53.80% Profit Margin- Rel Volume0.39 Prev Close2.76
ShortableYes LT Debt/Eq- EarningsNov 09 AMC Payout- Avg Volume174.33K Price2.83
Recom3.00 SMA20-4.94% SMA50-2.15% SMA200-20.05% Volume68,589 Change2.54%
Aug-12-16Downgrade Brean Capital Buy → Hold
Mar-11-16Downgrade Needham Buy → Hold
Mar-08-16Reiterated Needham Strong Buy $10 → $8
Sep-09-15Resumed JMP Securities Mkt Outperform
Aug-07-15Reiterated Needham Strong Buy $12 → $10
Aug-07-15Reiterated Brean Capital Buy $17 → $14
Jun-29-15Initiated Brean Capital Buy $17
Apr-28-15Reiterated Needham Strong Buy $16 → $12
Apr-22-15Initiated Piper Jaffray Overweight $14
Mar-26-15Initiated Oppenheimer Outperform $15
Feb-26-15Reiterated Needham Strong Buy $12 → $16
Nov-11-14Reiterated Needham Strong Buy $10 → $12
May-27-14Upgrade Aegis Capital Hold → Buy
May-15-14Upgrade Needham Buy → Strong Buy $6.30 → $10
Nov-13-13Reiterated Needham Buy $6 → $5
Oct-21-13Downgrade Aegis Capital Buy → Hold $3
Jul-26-13Downgrade Cantor Fitzgerald Hold → Sell $3 → $2.50
May-15-13Reiterated Cantor Fitzgerald Hold $7 → $3
May-14-13Reiterated Needham Buy $8 → $6
Mar-19-13Reiterated Needham Buy $11 → $8
Oct-18-17 07:40AM  Platinex Appoints Special Committee to Evaluate Cannabis Opportunities and Updates Its Cannabis Strategy GlobeNewswire
Oct-17-17 04:05PM  Pernix Therapeutics Announces Planned Departure of Chief Financial Officer GlobeNewswire
09:57AM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : October 17, 2017 Capital Cube
Aug-18-17 05:49PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : August 18, 2017 Capital Cube
Aug-12-17 07:55AM  Edited Transcript of PTX earnings conference call or presentation 27-Jul-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-08-17 05:03PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : August 8, 2017 Capital Cube
Aug-01-17 11:51AM  Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 1, 2017 Capital Cube
Jul-27-17 04:01PM  Pernix Therapeutics Reports Second Quarter 2017 Financial Results and Provides Business Update GlobeNewswire
12:00PM  Investor Network: Pernix Therapeutics Holdings, Inc. to Host Earnings Call ACCESSWIRE
Jul-20-17 04:54PM  Pernix Commences Refinancing Transactions to Fortify Balance Sheet GlobeNewswire
04:53PM  Pernix Therapeutics Pre-Announces Certain Preliminary Second Quarter 2017 Financial Results GlobeNewswire
Jun-28-17 04:01PM  Pernix Therapeutics Added to Russell Microcap® Index GlobeNewswire
Jun-13-17 12:51PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : June 13, 2017 Capital Cube +5.71%
May-31-17 12:43PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : May 31, 2017 Capital Cube
May-21-17 06:54PM  Edited Transcript of PTX earnings conference call or presentation 15-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-19-17 09:30AM  Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017 Capital Cube
May-16-17 12:58PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : May 16, 2017 Capital Cube -21.12%
May-15-17 04:01PM  Pernix Therapeutics Reports First Quarter 2017 Financial Results and Provides Business Update GlobeNewswire
02:30PM  Investor Network: Pernix Therapeutics Holdings, Inc. to Host Earnings Call Accesswire
May-08-17 04:01PM  Pernix Therapeutics to Report First Quarter 2017 Financial Results on Monday, May 15 GlobeNewswire
May-04-17 04:15PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : May 4, 2017 Capital Cube +24.36%
May-01-17 08:00AM  Pernix Therapeutics Provides Update on Availability of Zohydro® ER with BeadTek 20mg Strength GlobeNewswire +5.04%
Apr-24-17 07:30AM  Rennova Health and Pernix Therapeutics Both Led In the Pharma Arena with Significant Share Price Jumps Accesswire
Apr-19-17 02:32PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : April 19, 2017 Capital Cube
Apr-18-17 04:00PM  Platinex Inc.-Proposed Private Placement Marketwired
Apr-07-17 05:19PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : April 7, 2017 Capital Cube +5.37%
Apr-05-17 08:41AM  Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017 Capital Cube -6.52%
08:41AM  Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017
Apr-01-17 01:04PM  PERNIX THERAPEUTICS HOLDINGS, INC. Financials
Mar-30-17 09:30AM  Today's Research Reports on Biotech Stocks to Watch: Catalyst Biosciences and Pernix Therapeutics Accesswire
Mar-29-17 10:10AM  Tuesdays Top Biopharma Movers -13.05%
Mar-28-17 11:07PM  Edited Transcript of PTX earnings conference call or presentation 28-Mar-17 8:30pm GMT Thomson Reuters StreetEvents
11:07PM  Edited Transcript of PTX earnings conference call or presentation 28-Mar-17 8:30pm GMT
04:39PM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 10-K, Annual Report
04:01PM  Pernix Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
07:07AM  Q4 2016 Pernix Therapeutics Holdings Inc Earnings Release - After Market Close
Mar-23-17 04:44PM  Pernix: An Investor's Rationale to Staying Long GuruFocus.com
04:44PM  Pernix: An Investor's Rationale to Staying Long
Mar-16-17 12:14AM  Webcast-Q4 Earnings Call for Pernix Therapeutics Holdings, Inc. at Company Spotlight
Mar-15-17 04:01PM  Pernix Therapeutics to Report Fourth Quarter and Year-End 2016 Financial Results on Tuesday, March 28 GlobeNewswire
Feb-23-17 09:30AM  Biotech's Rise Shows No Sign of Slowing Dow in 2017: Today's Reports on Pernix Therapeutics and Brainstorm Cell Therapeutics Accesswire +19.70%
08:00AM  Pernix Therapeutics Prevails in Zohydro® ER ANDA Litigation GlobeNewswire
Feb-03-17 08:00AM  Pernix Therapeutics Provides Update on Arbitration GlobeNewswire -18.12%
Jan-20-17 01:51PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : January 20, 2017
Jan-06-17 04:01PM  Pernix Therapeutics Appoints Ken Piña as General Counsel and Chief Compliance Officer GlobeNewswire +28.65%
12:05PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : January 6, 2017
Jan-05-17 09:55AM  Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q3, 2016 By the Numbers : January 5, 2017
Dec-07-16 08:15AM  Blog Coverage Teva Reports Positive Outcome for the European Label for COPAXONE®; Replaces Generics Head Accesswire
Nov-29-16 04:06PM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Nov-22-16 06:36AM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statement
06:30AM  Pernix Therapeutics Appoints New Board Member GlobeNewswire
Nov-10-16 04:46PM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
04:01PM  Pernix Therapeutics Reports Third Quarter 2016 Financial Results and Provides Business Update GlobeNewswire
07:07AM  Q3 2016 Pernix Therapeutics Holdings Inc Earnings Release - After Market Close
Nov-07-16 05:09PM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statement +7.24%
04:01PM  Pernix Therapeutics Appoints Two Board Members GlobeNewswire
Nov-01-16 02:47PM  Drug Makers Stocks Under Scanner -- Pernix Therapeutics, Novo Nordisk, Synergy Pharma, and Apricus Biosciences PR Newswire
Oct-31-16 04:30PM  Pernix Therapeutics to Report Third Quarter 2016 Financial Results on November 10, 2016 GlobeNewswire
12:31AM  Drugmakers Turn Cheap Generics Into Expensive Pills at The Wall Street Journal
Oct-30-16 01:42PM  Drugmakers Turn Cheap Generics Into Expensive Pills at The Wall Street Journal
Oct-24-16 12:30PM  Edited Transcript of PTX earnings conference call or presentation 11-Aug-16 8:30pm GMT
Oct-14-16 11:08AM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : October 14, 2016
07:03AM  Splits Calendar: Pernix Therapeutics splits before market open today (1:10 ratio)
Oct-13-16 08:57AM  Pernix Therapeutics Announces Reverse Stock Split and Corporate Governance Enhancements GlobeNewswire -25.81%
08:56AM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendment
Sep-28-16 04:01PM  Pernix Therapeutics Announces Distribution of TREXIMET® 10/60 mg (sumatriptan 10mg and naproxen sodium 60 mg) Dose For Use in Pediatric Patients GlobeNewswire
Sep-21-16 10:55AM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : September 21, 2016
Sep-16-16 07:00AM  Marsha Stanton, Ph.D., RN, Pernix Therapeutics Executive Director of Medical and Government Affairs, Awarded Prestigious Pain Management Advocacy Award from the American Society for Pain Management Nursing® GlobeNewswire
Sep-14-16 07:00AM  Pernix Therapeutics Announces the Issuance of Two New Orange Book Listed Patents for Zohydro® ER with BeadTek GlobeNewswire
Sep-09-16 08:00AM  Pernix Therapeutics Announces Significant Presence at PAINWeek 2016 GlobeNewswire
Sep-07-16 11:03AM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : September 7, 2016
Aug-12-16 06:14AM  Pernix Therapeutics downgraded by Brean Capital -5.93%
Aug-11-16 04:49PM  Pernix Therapeutics reports 2Q loss
04:40PM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
04:01PM  Pernix Therapeutics Reports Second Quarter 2016 Financial Results and Business Update GlobeNewswire
07:07AM  Q2 2016 Pernix Therapeutics Holdings Inc Earnings Release - After Market Close
Aug-04-16 03:12PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : August 4, 2016 +15.35%
06:30AM  Pernix Therapeutics to Report Second Quarter 2016 Financial Results on August 11, 2016 GlobeNewswire
Jul-26-16 05:41PM  Pernix Therapeutics Announces Reorganization of Senior Management Team GlobeNewswire
Jul-18-16 02:12PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : July 18, 2016
Jul-08-16 12:06PM  These 5 Stocks Are Breaking Out +11.36%
Jul-07-16 04:53PM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits +11.86%
09:21AM  Todays Hot Stocks: Buckle, Boeing, Ford, and More at Insider Monkey
06:30AM  Pernix Therapeutics Announces Restructuring of Sales Force and Operations GlobeNewswire
Jun-22-16 10:31AM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing
08:52AM  Research Report Initiated on Select Healthcare Equities
Jun-21-16 01:12PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : June 21, 2016
Jun-16-16 08:00AM  Pernix Therapeutics Announces Positive Phase IV Results of Silenor® vs. Zolpidem Head-to-Head Arousability Study GlobeNewswire +12.52%
Jun-09-16 11:06AM  5 Stocks Under $10 Set to Soar +9.54%
Jun-07-16 05:45PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : June 7, 2016
04:16PM  Steven Cohen Adds to Stake in Pernix Therapeutics
May-31-16 08:34AM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-26-16 07:37AM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -11.37%
May-25-16 08:00AM  Pernix Therapeutics Announces the Issuance of Three New Orange Book Patents for Zohydro® ER with BeadTek GlobeNewswire
May-19-16 04:01PM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing
May-18-16 10:47PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : May 19, 2016
May-17-16 03:51PM  Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q1, 2016 By the Numbers -5.82%
May-11-16 01:51PM  Pernix Therapeutics Names John Sedor As Chairman and Interim CEO In Place Of Dough Drysdale -17.04%
08:02AM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing
08:00AM  Pernix Therapeutics Announces CEO Transition GlobeNewswire
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs primarily for the United States market. It targets underserved therapeutic areas, such as central nervous system (CNS), including neurology, pain, and psychiatry. The company's products comprise Treximet, a fixed dose combination product indicated for the treatment of acute migraine; Zohydro ER with BeadTek, an opioid agonist indicated for the management of pain; and Silenor, a non-narcotic, non-scheduled, and non-addictive prescription sleep aid for the treatment of insomnia characterized by difficulty with sleep maintenance. Pernix Therapeutics Holdings, Inc. markets and sells its non-core products, including generics through its wholly owned subsidiaries; and markets its non-promoted products through distributors and trade partners. It serves drug wholesalers, retail drug stores, mass merchandisers, and grocery store pharmacies. Pernix Therapeutics Holdings, Inc. was founded in 1996 and is headquartered in Morristown, New Jersey.